MedPage Today3h
CBD-Coated Tampons? FDA Says No Way
The agency recently sent a warning letter to the company's CEO, Valentina Milanova, noting that an inspection of the ...
FiercePharma11d
FDA digs in its heels with another rejection for Lexicon's diabetes prospect Zynquista
Lexicon Pharmaceuticals has already thrown in the towel on its commercial efforts after a years-long uphill battle to get its ...
JD Supra7h
FDA Announced Removal of Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...
Yahoo Finance4d
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
“As we entered 2024, the Company had three primary goals in our quest to ensure we are ready for the successful commercial launch of LIBERTY in 2025: 1) complete FDA 510(k) submission ...